Genotyping, Pandrug Resistance, Extensively Drug-Resistant, and Multi Drug-Resistance Detection of Pseudomonas aeruginosa Isolated From Patients in the West of Iran

被引:0
|
作者
Rouhi, Samaneh [1 ,2 ]
Ramazanzadeh, Rashid [2 ,3 ]
Nouri, Bijan [4 ]
机构
[1] Kurdistan Univ Med Sci, Student Res Comm, Sanandaj, Iran
[2] Kurdistan Univ Med Sci, Cellular & Mol Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran
[3] Kurdistan Univ Med Sci, Microbiol Dept, Sanandaj, Iran
[4] Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran
关键词
Genotyping; Pandrug Resistance; Extensively Drug resistance; Multidrug resistance; Pseudomonas aeruginosa; ACINETOBACTER-BAUMANNII; INFECTIONS; PATTERN; ADULT; PCR;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Resistance to multiple antibiotic classes is called multidrug resistance (MDR), extremely drug resistance (XDR), and pandrug resistance (PDR). In addition, the genotyping survey of resistant bacteria is a prominent factor in epidemiological surveying. Therefore, the present study aimed to conduct an epidemiological survey in order to detect XDR, MDR, and PDR of Pseudomonas aeruginosa isolated from clinical specimens in Kurdistan province, Iran. Materials and Methods: During (December) 2015-(August) 2017, a total of 134 strains of P. aeruginosa were detected by the polymerase chain reaction and were tested for antibiotic resistance, MDR, XDR, and PDR. The related specimens of the patients with nosocomial infections were subjected to BOX-PCR analysis. Finally, the data were analyzed using Stata software with frequency determination, Fisher exact test, and Logistic regression (P = 0.05). BOX-PCR analysis was performed by GelJ version 1.13 software. Results: Based on the results, the lowest and highest resistance and susceptibility rates in 134 isolates of P. aeruginosa were related to cefpodoxime (93.28%), imipenem (27.61%), colistin (69.40%), and cefpodoxime (6.71%), respectively. In addition, MDR and XDR isolates were observed in 97.76% and 15.67% of P. aeruginosa isolates, respectively. However, PDR was detected in none of the isolates while BOX-PCR demonstrated four main clusters with 56 unique patterns in nosocomial infection isolates. Further, a significant relationship was observed between MDR and XDR isolates and nosocomial infection (P = 0.05). Eventually, there was a significant association between ward, the type of specimens, and hospitals with nosocomial infection (P = 0.05). Conclusions: In general, a high frequency of antibiotic resistance was observed in this study whereas no genetic correlation was observed between P. aeruginosa strains. In sum, selecting the most effective antibiotics and devising an efficient way for controlling the antibiotic resistance should be taken into consideration.
引用
收藏
页码:170 / 177
页数:8
相关论文
共 50 条
  • [41] Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia
    Khawcharoenporn, Thana
    Chuncharunee, Alan
    Maluangnon, Chailat
    Taweesakulvashra, Thitiporn
    Tiamsak, Pimsiri
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (06) : 828 - 834
  • [42] EVOLUTION AND UTILITY OF A PSEUDOMONAS-AERUGINOSA DRUG-RESISTANCE FACTOR
    OLSEN, RH
    HANSEN, J
    JOURNAL OF BACTERIOLOGY, 1976, 125 (03) : 837 - 844
  • [43] Pyrazinamide resistance in MDR and extensively drug-resistant tuberculosis.
    Yao, Lan
    Zhang, Qing
    Liu, Yidan
    Xiao, Heping
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (08): : 3532 - 3536
  • [44] A case of resistance beyond extensively drug-resistant tuberculosis in Japan
    Kanamori, Hajime
    Uchiyama, Bine
    Mitarai, Satoshi
    Hatakeyama, Takashi
    Aso, Noboru
    Kaku, Mitsuo
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 870 - 872
  • [45] Extensively Drug-Resistant Tuberculosis: Principles of Resistance, Diagnosis, and Management
    Wilson, John W.
    Tsukayama, Dean T.
    MAYO CLINIC PROCEEDINGS, 2016, 91 (04) : 482 - 495
  • [46] Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy
    Fernandez-Esgueva, Marta
    Isabel Lopez-Calleja, Ana
    Mulet, Xavier
    Fraile-Ribot, Pablo A.
    Cabot, Gabriel
    Huarte, Rafael
    Rezusta, Antonio
    Oliver, Antonio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2020, 38 (10): : 474 - 478
  • [47] What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi-and Extensively Drug-Resistant Tuberculosis
    Heyckendorf, Jan
    Andres, Soenke
    Koser, Claudio U.
    Olaru, Ioana D.
    Schon, Thomas
    Sturegard, Erik
    Beckert, Patrick
    Schleusener, Viola
    Kohl, Thomas A.
    Hillemann, Doris
    Moradigaravand, Danesh
    Parkhill, Julian
    Peacock, Sharon J.
    Niemann, Stefan
    Lange, Christoph
    Merker, Matthias
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (02)
  • [48] BIOCHEMISTRY IDENTIFICATION AND DRUG-RESISTANCE OF PSEUDOMONAS SPECIES ISOLATED FROM HOSPITALIZED-PATIENTS
    WATANABE, DSA
    MORENO, G
    REVISTA BRASILEIRA DE MEDICINA, 1977, 34 (06) : 393 - 396
  • [49] Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients
    Vourli, S.
    Frantzeskaki, F.
    Meletiadis, J.
    Stournara, L.
    Armaganidis, A.
    Zerva, L.
    Dimopoulos, G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (06) : 670 - 671
  • [50] Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates
    Holbrook, Selina Y. L.
    Garneau-Tsodikova, Sylvie
    MICROBIAL DRUG RESISTANCE, 2018, 24 (07) : 1020 - 1030